Web3 VCs in Japan
3 funds and 20 venture capitalists based in Japan.
Funds
gumi Cryptos CapitalAUM: $100M · Est. 2018 · 4 team · 75 investmentsNewton BiocapitalEst. 2016 · 15 team · 0 investmentsMZ Web3 FundAUM: $100M · 1 team · 0 investments
Investors
Goro TakedaFounderNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Dirk BoogmansVice-Chairman and Chairman of the Audit Committee of NBC I and NBC IINewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Jean CombalbertIndependent DirectorNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Jean-Claude DeschampsChairman Emeritus and Advisor to the Board of NBC I and NBC IINewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Evans HuangfuPartnergumi Cryptos Capital
gCC's older first-party FAQ stated typical $250K–$1M checks at friends-and-family through pre-Series A, occasionally Series A. Treat this as historical firm guidance—not Evans's personal or necessarily current range—and confirm Fund II sizing, lead appetite and structure directly.Web3Blockchain InfrastructureGaming
Rui ZhangManaging Partnergumi Cryptos Capital
A December 2019 gCC FAQ said the firm typically wrote $250K–$1M checks. Treat this only as a dated historical range, not a current promise: gCC subsequently raised a $110M Fund II and has not published an updated range on its current site. Confirm stage, instrument, ownership and reserves directly.Blockchain InfrastructureCrypto ProtocolsDeFi
Alain ParthoensChief Executive OfficerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Sadashi SuzukiJapan RepresentativeNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Guy HeynenChief Medical and Regulatory OfficerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Michihiko WadaChief Regulatory and Development OfficerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Danny GonnissenChief Operating OfficerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Pierre DetrixheVenture DirectorNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Tomoko AsaokaPartnerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Dario PadovaniChief Financial OfficerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Daisuke MorishitaVenture PartnerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Toko SennaAssistant to the CEO / Office ManagerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Ajit ShettyChairman of the Board of NBC I and NBC IINewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Hironao KunimitsuFoundergumi Cryptos Capital
GamingNFTs
Miki IsakariInvestment ManagerMZ Web3 Fund
Web3MetaverseGaming
Miko MatsumuraManaging Partnergumi Cryptos Capital